| [1] |
CHEN Xiaodan, ZHOU Shu, LYU Yanru, XU Zhiyong, LAN Haiyan, LU Shui, GAO Shan, SHU Liuyang, LIN Siyang, HAO Yanrong, XIE Yanyan.
Study on the initial titration dose and genetic polymorphism of oxycodone hydrochloride prolonged-release tablets in the treatment of severe cancer pain
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 74-80.
|
| [2] |
LIU Jingqian, ZHANG Yajing.
Strategies for prevention,control and management of CAR-T cell therapy related adverse reactions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 540-548.
|
| [3] |
WANG Huilin, JIANG Wei, YU Qitao.
Progress in the application of patient?reported outcomes in tumor immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 255-260.
|
| [4] |
BAI Mengcai, YAN Zeyu, SHI Caiyu, XING Jinliang, REN Tingting .
Research progress on functional heterogeneity of mitochondrial oxidative phosphorylation in tumor #br#
#br#
cells #br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 114-119.
|
| [5] |
GUO Enhui, CHENG Bing, FENG Siqi, MA Ting .
Research progress of biological clock gene Bmal1 in tumor
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 570-575.
|
| [6] |
LI Meile, JIN Kai, TANG Ting, GUO Ju, ZHAO Ziyue, Xie Yu'an.
Research progress in the regulation of non-coding RNA by ginsenoside for anti-tumor
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 576-580.
|
| [7] |
LIN Qian, FAN Huiming, ZOU You, CHEN Shiming.
Research progress of copper and its compounds in anti-tumor therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 328-334.
|
| [8] |
TANG Lili.
CACA guidlines for holistic integrative management of cancer·Psychotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 109-117.
|
| [9] |
LIU Siyang, TANG Enyu, XU Guangquan.
Research progress on regulatory mechanisms and therapeutic strategies for drug tolerant persister cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 235-239.
|
| [10] |
WEI Chong, ZHAO Danqing, ZHANG Yan, WANG Wei, ZHANG Wei, ZHOU Daobin .
Chidamide combined with azacitidine in treating relapsed/refractory angioimmunoblastic T⁃cell lymphoma: a prospective clinical study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 51-55.
|
| [11] |
LI Wei, MA Shishi, CHEN Xiaopin.
Effect of viral infection on antitumor therapy in patients with malignant tumors and antiviral strategies
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 85-91.
|
| [12] |
LIU Yan, JIA Yuxian, LI Tingting.
Research progress of cytokine release syndrome due to tumor immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 575-580.
|
| [13] |
QIU Liyan, YANG Li.
Application value of internet-based continuous management for nasopharyngeal carcinoma patients with symptoms 5 years after hospital discharge
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 314-319.
|
| [14] |
DI Yuqin, DING Yufeng, WANG Xiongjun.
Research progress of tumor metabolic reprogramming in chemotherapy resistance and immunotherapy tolerance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 139-146.
|
| [15] |
WANG Binru, CHEN Shiming.
Research progress on explosive tumor progression induced by targeted PD-1 and PD-L1 immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 218-223.
|
